JIM
DVAX

Jupiter Investment Management’s Dynavax Technologies DVAX Stock Holding History

Jupiter Investment Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$168K Buy
+19,018
New +$96.1K ﹤0.01% 377

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Jupiter Investment Management's DVAX Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Dynavax Technologies (DVAX) in Q2 2020: 19,018 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings.

151 funds tracked by Wall St. Rank hold DVAX as of Q2 2020.

  • Jupiter Investment Management held 19,018 shares of Dynavax Technologies worth $168K as of Q2 2020.
  • Dynavax Technologies was a new Jupiter Investment Management position in Q2 2020.
  • Dynavax Technologies made up ﹤0.01% of Jupiter Investment Management's portfolio in Q2 2020, its #377 holding.
  • 151 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.